I don't know there will be a CR. It seems to me that from the below comment regarding this half of the FY, there is an eagerness to make a deal. Potentially discussions may have already started, now it's all about waiting for the data:
Sharing data and discussions on the Company’s antiviral programs including the HIV-1 and COVID-19 Phase
2 clinical trials with potential pharmaceutical company partners with a view to commercialisation of the
Company’s antiviral intellectual property.
Ann: Half Yearly Report and Accounts, page-69
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $23.46M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.8¢ | 2.6¢ | $3.254K | 120.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 232048 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 264517 | 2 |
View Market Depth
| Last trade - 15.57pm 28/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |